Early Phase Studies
Fast Track Approvals: Experience expedited regulatory approval in Moldova just 2 weeks from submission
These studies are essential for establishing a comprehensive understanding of a drug’s safety and efficacy profile before proceeding to later-stage clinical trials.
Early-phase clinical trials are a critical component in the development of new medical treatments, primarily focusing on evaluating safety, tolerability, and initial efficacy. These trials typically include Phase I and Phase II studies.
In addition to these phases, early development studies may include specialized assessments such as drug-drug interaction studies, pharmacokinetic evaluations in patients with different chronic diseases, gender-specific studies, and investigations into food or other.
Phase I Clinical Studies Excellence at 3S Pharma
Phase I Clinical Studies aim to assess a drug’s safety profile in humans, determine how the body processes the drug (pharmacokinetics), and understand the drug’s effects on the body (pharmacodynamics).




Phase 2 Clinical Studies Excellence at 3S Pharma
Phase 2 clinical study focuses on therapeutic efficacy and safety and is conducted on hundreds of participants, amongst whom there are patients diagnosed with the disease or condition that the drug is being developed to treat.
In Phase 2 clinical study we also start to collect relevant data about the medication efficacy.